Honokiol regulates Acute respiratory distress syndrome (ARDS)‐associated pulmonary fibrosis via the miR‐19a‐3p/POSTN axis
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70580 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Weilun Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Respiratory Distress Syndrome, Lignans, Biphenyl Compounds. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kaohsiung Medical University Hospital, National Science and Technology Council, Kaohsiung Medical University.
Abstract (Originalsprache)
Background and Purpose Acute respiratory distress syndrome (ARDS) and subsequent pulmonary fibrosis are associated with high mortality and limited treatment options. Periostin (POSTN) is a profibrotic mediator predicted to be regulated by microRNA‐19a‐3p (miR‐19a‐3p), but the relevance of this axis in ARDS‐associated pulmonary fibrosis remains unclear. Honokiol (HKL), a phytochemical derived from Magnolia officinalis , possesses antioxidant and anti‐inflammatory properties. This study investigated whether HKL modulates the miR‐19a‐3p/POSTN axis in ARDS‐associated lung injury and fibrosis. Experimental Approach Serum POSTN and miR‐19a‐3p levels were measured in patients with ARDS and correlated with severity. Mechanistic studies were performed using a lipopolysaccharide (LPS)‐induced lung injury mouse model and macrophage–epithelial and macrophage–fibroblast co‐culture systems. Key Results Patients with ARDS exhibited elevated serum POSTN and reduced miR‐19a‐3p, which were inversely correlated and associated with indices of disease severity. HKL attenuated LPS‐induced lung injury and fibrotic responses, accompanied by reduced POSTN expression and preserved miR‐19a‐3p levels. Dual‐luciferase reporter assays supported a regulatory interaction between miR‐19a‐3p and POSTN. HKL was associated with alterations in macrophage phenotype and reduced macrophage‐associated POSTN expression. In co‐culture systems, manipulation of miR‐19a‐3p in macrophages modulated epithelial apoptotic signalling and fibroblast activation. In vitro loss‐of‐function experiments suggested that miR‐19a‐3p contributes, at least in part, to HKL‐associated protective effects. Conclusion and Implications The miR‐19a‐3p/POSTN axis may represent a regulatory pathway associated with ARDS‐related lung injury and fibrosis. HKL attenuated experimental injury and fibrotic responses in association with this axis. These findings support further pharmacological investigation of HKL in ARDS‐associated lung injury and fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
- Department of Critical Care Medicine, Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City, Taiwan.
- Center for Health Research and Innovation, Fu Jen Catholic University, New Taipei City, Taiwan.
- Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Gangshan Hospital, Kaohsiung, Taiwan.
ORCID-Profile: Weilun Liu, Hsiaohsuan Wang, Hsuanfu Kuo, Chiahung Yen, Modasang Hua, Chiayuan Chang, Zhiwei Xu, Ifan Liu, Chongchao Hsieh, Chihhsin Hsu, Chiayang Li, Shuchi Wang, Yunghsiang Chen, Menghsuan Cheng, Polen Liu
Förderung
- Kaohsiung Medical University Hospital
- National Science and Technology Council
- Kaohsiung Medical University
- Regenerative Medicine and Cell Therapy Research Center, Kaohsiung Medical University
- China Medical University
- Kaohsiung Medical University Chung-Ho Memorial Hospital
Zitieren
APA
Liu, W., Wang, H., Kuo, H., Yen, C., Hua, M., Chang, C., Xu, Z., Liu, I., Hsieh, C., Hsu, C., Li, C., Wang, S., Chen, Y., Cheng, M., & Liu, P. (2026). Honokiol regulates Acute respiratory distress syndrome (ARDS)‐associated pulmonary fibrosis via the miR‐19a‐3p/POSTN axis. British Journal of Pharmacology. https://doi.org/10.1111/bph.70580
Vancouver
Liu W, Wang H, Kuo H, Yen C, Hua M, Chang C, et al. Honokiol regulates Acute respiratory distress syndrome (ARDS)‐associated pulmonary fibrosis via the miR‐19a‐3p/POSTN axis. British Journal of Pharmacology. 2026. doi:10.1111/bph.70580
BibTeX
@article{Liu2026,
author = {Liu, Weilun and Wang, Hsiaohsuan and Kuo, Hsuanfu and Yen, Chiahung and Hua, Modasang and Chang, Chiayuan and Xu, Zhiwei and Liu, Ifan and Hsieh, Chongchao and Hsu, Chihhsin and Li, Chiayang and Wang, Shuchi and Chen, Yunghsiang and Cheng, Menghsuan and Liu, Polen},
title = {Honokiol regulates Acute respiratory distress syndrome (ARDS)‐associated pulmonary fibrosis via the miR‐19a‐3p/POSTN axis},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70580}
}
EUVIMED